Korea Arlico PharmLtd Dividends and Buybacks
Dividend criteria checks 1/6
Korea Arlico PharmLtd is a dividend paying company with a current yield of 3.62%. Next payment date is on 14th April, 2025 with an ex-dividend date of 27th December, 2024.
Key information
3.6%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | 14 Apr 25 |
| Ex dividend date | 27 Dec 24 |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
Recent updates
Korea Arlico PharmLtd (KOSDAQ:260660) Is Carrying A Fair Bit Of Debt
Nov 12
There's Reason For Concern Over Korea Arlico Pharm Co.,Ltd.'s (KOSDAQ:260660) Price
Aug 04Is Korea Arlico PharmLtd (KOSDAQ:260660) Using Too Much Debt?
Mar 24Should You Be Adding Korea Arlico PharmLtd (KOSDAQ:260660) To Your Watchlist Today?
Mar 02Korea Arlico PharmLtd's (KOSDAQ:260660) Shareholders Are Down 50% On Their Shares
Feb 12
What Is The Ownership Structure Like For Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)?
Jan 25Should You Use Korea Arlico PharmLtd's (KOSDAQ:260660) Statutory Earnings To Analyse It?
Jan 04Is Korea Arlico PharmLtd (KOSDAQ:260660) A Risky Investment?
Dec 16Are Strong Financial Prospects The Force That Is Driving The Momentum In Korea Arlico Pharm Co.,Ltd.'s KOSDAQ:260660) Stock?
Nov 25Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if A260660's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if A260660's dividend payments have been increasing.
Dividend Yield vs Market
| Korea Arlico PharmLtd Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A260660) | 3.6% |
| Market Bottom 25% (KR) | 1.2% |
| Market Top 25% (KR) | 4.0% |
| Industry Average (Pharmaceuticals) | 1.1% |
| Analyst forecast (A260660) (up to 3 years) | n/a |
Notable Dividend: A260660's dividend (3.62%) is higher than the bottom 25% of dividend payers in the KR market (1.22%).
High Dividend: A260660's dividend (3.62%) is low compared to the top 25% of dividend payers in the KR market (3.99%).
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate A260660's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as A260660 has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/04 07:39 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Korea Arlico Pharm Co.,Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jongsun Park | Eugene Investment & Securities Co Ltd. |